T. Rowe Price Health Sciences Fund (PRHSX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
76.00
+0.11 (0.14%)
Jun 5, 2025, 4:00 PM EDT
PRHSX Holdings List
As of Mar 31, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | LLY | Eli Lilly and Company | 10.72% |
2 | UNH | UnitedHealth Group Incorporated | 7.11% |
3 | ISRG | Intuitive Surgical, Inc. | 4.92% |
4 | SYK | Stryker Corporation | 4.45% |
5 | TMO | Thermo Fisher Scientific Inc. | 3.94% |
6 | n/a | ARGENX SE | 3.54% |
7 | VRTX | Vertex Pharmaceuticals Incorporated | 3.27% |
8 | BSX | Boston Scientific Corporation | 3.14% |
9 | DHR | Danaher Corporation | 3.07% |
10 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.51% |
11 | ELV | Elevance Health, Inc. | 2.20% |
12 | AZN | AstraZeneca PLC | 1.90% |
13 | CI | The Cigna Group | 1.85% |
14 | INSM | Insmed Incorporated | 1.61% |
15 | MRK | Merck & Co., Inc. | 1.60% |
16 | REGN | Regeneron Pharmaceuticals, Inc. | 1.57% |
17 | AMGN | Amgen Inc. | 1.52% |
18 | n/a | BEIGENE LTD | 1.51% |
19 | GILD | Gilead Sciences, Inc. | 1.45% |
20 | SNY | Sanofi | 1.21% |
21 | PEN | Penumbra, Inc. | 1.20% |
22 | ASND | Ascendis Pharma A/S | 1.20% |
23 | BPMC | Blueprint Medicines Corporation | 1.11% |
24 | HCA | HCA Healthcare, Inc. | 0.90% |
25 | TRPGRIA | T. Rowe Price Government Reserve Fund | 0.76% |
26 | MOH | Molina Healthcare, Inc. | 0.72% |
27 | BDX | Becton, Dickinson and Company | 0.72% |
28 | VRNA | Verona Pharma plc | 0.70% |
29 | THC | Tenet Healthcare Corporation | 0.69% |
30 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 0.68% |
31 | NTRA | Natera, Inc. | 0.64% |
32 | RNA | Avidity Biosciences, Inc. | 0.58% |
33 | NBIX | Neurocrine Biosciences, Inc. | 0.54% |
34 | SRRK | Scholar Rock Holding Corporation | 0.53% |
35 | IDXX | IDEXX Laboratories, Inc. | 0.52% |
36 | ZLAB | Zai Lab Limited | 0.52% |
37 | MCK | McKesson Corporation | 0.51% |
38 | COR | Cencora, Inc. | 0.49% |
39 | DGX | Quest Diagnostics Incorporated | 0.49% |
40 | RVMD | Revolution Medicines, Inc. | 0.46% |
41 | CAH | Cardinal Health, Inc. | 0.46% |
42 | n/a | NATIONAL RESILIENCE SER B CVT PFD STOCK | 0.45% |
43 | SWX: SOON | Sonova Holding AG | 0.45% |
44 | CVS | CVS Health Corporation | 0.41% |
45 | ACLX | Arcellx, Inc. | 0.41% |
46 | AKRO | Akero Therapeutics, Inc. | 0.41% |
47 | MLTX | MoonLake Immunotherapeutics | 0.41% |
48 | PTGX | Protagonist Therapeutics, Inc. | 0.40% |
49 | CNTA | Centessa Pharmaceuticals plc | 0.39% |
50 | CNC | Centene Corporation | 0.37% |
51 | EXAS | Exact Sciences Corporation | 0.37% |
52 | RVTY | Revvity, Inc. | 0.36% |
53 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.35% |
54 | ALKS | Alkermes plc | 0.33% |
55 | KRYS | Krystal Biotech, Inc. | 0.30% |
56 | VEEV | Veeva Systems Inc. | 0.29% |
57 | UTHR | United Therapeutics Corporation | 0.29% |
58 | PCVX | Vaxcyte, Inc. | 0.28% |
59 | TECH | Bio-Techne Corporation | 0.28% |
60 | BTSG | BrightSpring Health Services, Inc. | 0.28% |
61 | KYMR | Kymera Therapeutics, Inc. | 0.27% |
62 | BHVN | Biohaven Ltd. | 0.27% |
63 | RGEN | Repligen Corporation | 0.26% |
64 | RARE | Ultragenyx Pharmaceutical Inc. | 0.26% |
65 | OSCR | Oscar Health, Inc. | 0.26% |
66 | SLNO | Soleno Therapeutics, Inc. | 0.26% |
67 | AGIO | Agios Pharmaceuticals, Inc. | 0.25% |
68 | CRNX | Crinetics Pharmaceuticals, Inc. | 0.25% |
69 | n/a | METSERA INC IPO Common Stock lockup | 0.25% |
70 | SWTX | SpringWorks Therapeutics, Inc. | 0.25% |
71 | VERA | Vera Therapeutics, Inc. | 0.24% |
72 | PRCT | PROCEPT BioRobotics Corporation | 0.23% |
73 | IMCR | Immunocore Holdings plc | 0.22% |
74 | DNLI | Denali Therapeutics Inc. | 0.20% |
75 | BEAM | Beam Therapeutics Inc. | 0.20% |
76 | n/a | TREELINE BIO SER A-1 CVT PFD STOCK PP | 0.19% |
77 | DXCM | DexCom, Inc. | 0.18% |
78 | n/a | GENERATE BIO SER B CVT PFD STOCK PP | 0.18% |
79 | APGE | Apogee Therapeutics, Inc. | 0.18% |
80 | ETR: SRT3 | Sartorius Aktiengesellschaft | 0.17% |
81 | BIIB | Biogen Inc. | 0.17% |
82 | n/a | TREELINE BIO SER A CVT PFD STOCK PP | 0.17% |
83 | n/a | NATIONAL RESILIENCE SER C CVT PFD STOCK | 0.16% |
84 | EHC | Encompass Health Corporation | 0.16% |
85 | LEGN | Legend Biotech Corporation | 0.15% |
86 | n/a | Caris Life Sciences Inc - CARIS LIFE SCIENCES SER C CVT PFD PP | 0.15% |
87 | n/a | DELFI DIAGNOSTICS SR A CVT PFD STOCK PP | 0.13% |
88 | n/a | BLUEJAY THERAPEUTICS SER C CVT PFD PP | 0.13% |
89 | REPL | Replimune Group, Inc. | 0.13% |
90 | n/a | INSITRO SER B CVT PFD PP | 0.13% |
91 | RYTM | Rhythm Pharmaceuticals, Inc. | 0.13% |
92 | TARS | Tarsus Pharmaceuticals, Inc. | 0.13% |
93 | IMNM | Immunome, Inc. | 0.12% |
94 | n/a | CELLANOME SERIES A CVT PFD STOCK PP | 0.12% |
95 | IONS | Ionis Pharmaceuticals, Inc. | 0.12% |
96 | LH | Labcorp Holdings Inc. | 0.12% |
97 | MRUS | Merus N.V. | 0.12% |
98 | CYTK | Cytokinetics, Incorporated | 0.12% |
99 | n/a | ARSENAL BIOSCIENCES SER C CVT PFD PP | 0.11% |
100 | n/a | Tenax Therapeutics Inc - TENAX THERAPEUTICS PRE FUNDED WTS PP | 0.11% |
101 | IMCR.2.5 02.01.30 | IMMUNOCORE HOLDINGS PLC | 0.10% |
102 | IRON | Disc Medicine, Inc. | 0.10% |
103 | LNTH | Lantheus Holdings, Inc. | 0.10% |
104 | n/a | END EAVOR BIO SERIES B CVT PFD STOCK PP | 0.10% |
105 | n/a | CLEAR LABS SERIES C CVT PFD PP | 0.10% |
106 | ICLR | ICON Public Limited Company | 0.10% |
107 | n/a | Caris Life Sciences Inc - CARIS LIFE SER D CVT PFD STOCK PP | 0.09% |
108 | n/a | NUTCRACKER THERA SER C CVT PFD STOCK PP | 0.09% |
109 | n/a | AKTIS ONCOLOGY SER B CVTPFD PP | 0.09% |
110 | n/a | SEAPORT THERAPEUTICS SER B CVT PFD PP | 0.09% |
111 | n/a | INSITRO SER C CVT PFD PP | 0.09% |
112 | n/a | KARTOS THERAPEUTICS SR C CVT PFD STK PP | 0.09% |
113 | CGON | CG Oncology, Inc. | 0.09% |
114 | n/a | KARDIUM SERIES D6 CVT PFD STOCK PP | 0.08% |
115 | n/a | GENESIS THERA SEV B CVT PFD STOCK PP | 0.08% |
116 | HLXB | Helix Acquisition Corp. II | 0.08% |
117 | BCYC | Bicycle Therapeutics plc | 0.08% |
118 | n/a | DELFI DIAGNOSTICS SR B CVT PFD STOCK PP | 0.07% |
119 | n/a | OBSIDIAN THERAPEUTICS SR C CVT PFD STK PP | 0.07% |
120 | n/a | Freenome Inc - FREENOME HOLDINGS SER B CVT PFD PP | 0.07% |
121 | CLDX | Celldex Therapeutics, Inc. | 0.07% |
122 | n/a | ELEMENT BIOSCIENCES SER C CVT PFD STOCK | 0.07% |
123 | PRAX | Praxis Precision Medicines, Inc. | 0.07% |
124 | n/a | CHROMA MEDICINE SER I CVT PFD STOCK PP | 0.06% |
125 | n/a | VERILY LIFE SCIENCES LLC SER B UNITS PP | 0.06% |
126 | n/a | KARDIUM INC SER D-5 CVT PFD STOCK PP | 0.06% |
127 | WVE | Wave Life Sciences Ltd. | 0.06% |
128 | n/a | SALUDA MEDICAL SERIES D CVT PFD STOCK PP | 0.06% |
129 | PHVS | Pharvaris N.V. | 0.06% |
130 | n/a | CLEERLY SER C CVT PFD STK PP | 0.06% |
131 | n/a | GALVANIZE THERAPEUTICS CVT PROM NOTE PP | 0.06% |
132 | n/a | AVALYN PHARMA SER C-1 CVT PFD STOCK PP | 0.05% |
133 | XNCR | Xencor, Inc. | 0.05% |
134 | n/a | SCRIBE THERA SER B CVT PFD STOCK PP | 0.05% |
135 | RCKT | Rocket Pharmaceuticals, Inc. | 0.05% |
136 | n/a | ODYSSEY THERAPEUTICS SR B CVT PFD STK PP | 0.05% |
137 | n/a | KARDIUM INC CB CVT PROM NOTE PP | 0.05% |
138 | n/a | AFFINIVAX AFX3772 MILESTONE EVENT PP | 0.04% |
139 | n/a | EIKON THERAPEUTICS SER D CVT PFD STK PP | 0.04% |
140 | ORIC | ORIC Pharmaceuticals, Inc. | 0.04% |
141 | n/a | COLOR HEALTH SERIES D-1 CVT PFD STOCK PP | 0.04% |
142 | n/a | COLOR HEALTH SER D CVT PFD STOCK PP | 0.04% |
143 | n/a | Sionna Therapeutics, Inc. IPO Common Stock lockup | 0.04% |
144 | n/a | Freenome Inc - FREENOME HOLDINGS SER C CVT PFD PP | 0.04% |
145 | NVCR | NovoCure Limited | 0.04% |
146 | GLUE | Monte Rosa Therapeutics, Inc. | 0.04% |
147 | n/a | LUMICKS TECH SER D CVT PFD STOCK PP | 0.04% |
148 | PRTA | Prothena Corporation plc | 0.04% |
149 | n/a | EIKON THERA SERIES B-1 CVT PFD STOCK PP | 0.04% |
150 | EPA: ALSEN | Sensorion SA | 0.04% |
151 | n/a | FOG PHARMA SER D CVT PFD STOCK PP | 0.04% |
152 | n/a | RING THERA SER B CVT PFD STOCK PP | 0.04% |
153 | GPCR | Structure Therapeutics Inc. | 0.04% |
154 | n/a | EIKON THERA SERIES B CVT PFD STOCK PP | 0.04% |
155 | n/a | GENERATE BIOMEDICINES INC SER C CVT PFD | 0.04% |
156 | n/a | THIRD ARC BIO SER A CVT PFD PP | 0.04% |
157 | n/a | GALVANIZE THERA CVT PROM NOTE 12/24 PP | 0.04% |
158 | TC37G1B6 | REFLEXION MEDICAL INC CVT PFD SR C PP | 0.04% |
159 | ALLO | Allogene Therapeutics, Inc. | 0.03% |
160 | n/a | GENESIS THERA SER A CVT PFD STOCK PP | 0.03% |
161 | n/a | HONOR TECHNOLOGY SER D CVT PFD PP | 0.03% |
162 | n/a | FOG PHARMA SER E CVT PFD PP | 0.03% |
163 | n/a | Scholar Rock Holding Corp - SCHOLAR ROCK WTS 12.25 PP | 0.03% |
164 | n/a | FOG PHARMACEUTICALS SERIES C CVT PFD STOCK PP | 0.03% |
165 | n/a | Tessera Therapeutics, Inc. Series C | 0.03% |
166 | n/a | PAX Labs Inc - PAX LABS CLASS A COMMON PP | 0.03% |
167 | n/a | REFLEXION MEDICAL INC SR E CVT PFD PP | 0.03% |
168 | n/a | DNA Script SAS - DNA SCRIPT SERIES C CVT PFD STOCK PP | 0.03% |
169 | n/a | ENDEAVOR BIO SER C CVT PFD PP | 0.03% |
170 | SANA | Sana Biotechnology, Inc. | 0.03% |
171 | IDYA | IDEAYA Biosciences, Inc. | 0.02% |
172 | n/a | Freenome Inc - FREENOME HOLDINGS SER D CVT PFD PP | 0.02% |
173 | n/a | KARTOS THERAPEUTICS SR D CVT PFD STK PP | 0.02% |
174 | ORKA | Oruka Therapeutics, Inc. | 0.02% |
175 | n/a | HONOR TECHNOLOGY SER E CVT PFD STOCK PP | 0.02% |
176 | n/a | AFFINIVAX NEXT GEN PROD MILESTON EVNT PP | 0.02% |
177 | ARVN | Arvinas, Inc. | 0.02% |
178 | n/a | SALUDA MEDICAL INC SERIES E-1 CVT PFD PP | 0.02% |
179 | IOVA | Iovance Biotherapeutics, Inc. | 0.02% |
180 | n/a | SALUDA MEDICAL INC SERIES E CVT PFD PP | 0.02% |
181 | n/a | LARONDE SERIES B CVT PFD STOCK PP | 0.02% |
182 | LYEL | Lyell Immunopharma, Inc. | 0.02% |
183 | n/a | REFLEXION MEDICAL INC PP | 0.02% |
184 | n/a | Exact Sciences Corp - - EXACT SCIENCES CMO MILESTONE PP | 0.02% |
185 | n/a | RING THERAPEUTICS SER C CVT PFD STK PP | 0.02% |
186 | n/a | ELEMENT BIOSCIENCES SER D-1 CVT PFD PP | 0.02% |
187 | n/a | ELEMENT BIOSCIENCES SER D CVT PFD PP | 0.02% |
188 | n/a | SALUDA MEDICAL CVT PROM NOTE PP | 0.02% |
189 | n/a | ARBOR BIO SERIES B CVT PFD STOCK PP | 0.02% |
190 | TRDA | Entrada Therapeutics, Inc. | 0.02% |
191 | RLAY | Relay Therapeutics, Inc. | 0.02% |
192 | AURA | Aura Biosciences, Inc. | 0.02% |
193 | n/a | INSCRIPTA SERIES E CVT PFD STOCK PP | 0.02% |
194 | SYRE | Spyre Therapeutics, Inc. | 0.02% |
195 | n/a | TESSERA THERAPEUTICS SER D CVT PFD PP | 0.02% |
196 | n/a | REFLEXION MEDICAL INC CVT | 0.02% |
197 | CRGX | CARGO Therapeutics, Inc. | 0.02% |
198 | n/a | COLOR HEALTH SERIES E CVT PFD STOCK PP | 0.01% |
199 | n/a | Tenax Therapeutics Inc - Tenax Therapeutics, Inc | 0.01% |
200 | n/a | ARBOR BIO SERIES C CVT PFD STOCK PP | 0.01% |
201 | OBIO | Orchestra BioMed Holdings, Inc. | 0.01% |
202 | VYGR | Voyager Therapeutics, Inc. | 0.01% |
203 | n/a | CLEAR LABS SER D CVT PFD STOCK PP | 0.01% |
204 | n/a | CAPSULE CORP SERIES E CVT PFD STOCK PP | 0.01% |
205 | n/a | Exact Sciences Corp - EXACT SCIENCES FDA MILESTONE PP | 0.01% |
206 | n/a | BLUEJAY THERAPEUTICS SER C-1 CVT PFD PP | 0.01% |
207 | n/a | CAPSULE CORP SERIES 1-D CVT PFD STOCK | 0.01% |
208 | n/a | Freenome Inc - FREENOME HOLDINGS SER F CVT PFD PP | 0.01% |
209 | ANAB | AnaptysBio, Inc. | 0.01% |
210 | n/a | EIKON THERAPEUTICS SER C CVT PFD STK PP | 0.01% |
211 | n/a | EIKON THERAPEUTICS SER C-1 CVT PFD STK PP | 0.01% |
212 | KYTX | Kyverna Therapeutics, Inc. | 0.01% |
213 | n/a | PROFOUNBIO ESCROW FUND PAYMENT | 0.01% |
214 | IMRX | Immuneering Corporation | 0.01% |
215 | GBIO | Generation Bio Co. | 0.01% |
216 | PRLD | Prelude Therapeutics Incorporated | 0.00% |
217 | ANNX | Annexon, Inc. | 0.00% |
218 | n/a | ODYSSEY THERAPEUTICS SR C CVT PFD STK PP | 0.00% |
219 | ALEC | Alector, Inc. | 0.00% |
220 | CABA | Cabaletta Bio, Inc. | 0.00% |
221 | n/a | PROGNOMIQ INC PP | 0.00% |
222 | n/a | SALUDA MEDICAL WTS 1/23 PP | 0.00% |
223 | DNA | Ginkgo Bioworks Holdings, Inc. | 0.00% |
224 | WGSWW | GeneDx Holdings Corp. | 0.00% |
225 | n/a | AFFINIVAX EXPENSE FUND PP | 0.00% |
226 | RVMDW | Revolution Medicines, Inc. | 0.00% |
227 | n/a | CHROMACODE INC PP | 0.00% |
228 | n/a | PROFOUNDBIO EXPENSE FUND PYMT | 0.00% |
229 | n/a | SOMALOGIC INC | 0.00% |
230 | n/a | Ginkgo Bioworks Holdings Earn Out Shares $15.00 PP | 0.00% |
231 | n/a | Ginkgo Bioworks Holdings Earn Out Shares $17.50 PP | 0.00% |
232 | n/a | Gyroscope Therapeutics Ltd - GYROSCOPE THERAPEUTICS MILESTONE PAYMENT 2 PP | 0.00% |
233 | n/a | SALIOGEN THERA SERIES B CVT PFD STOCK PP | 0.00% |
234 | n/a | Ginkgo Bioworks Holdings Earn Out Shares $20.00 PP | 0.00% |
235 | n/a | Gyroscope Therapeutics Ltd - GYROSCOPE THERAPEUTICS MILESTONE PAYMENT 3 PP | 0.00% |
236 | n/a | Gyroscope Therapeutics Ltd - GYROSCOPE THERAPEUTICS MILESTONE PAYMENT 1 PP | 0.00% |
As of Mar 31, 2025